SCHEMBL22310263

SCHEMBL22310263

FC1(F)CCc2c(Cl)nc(Cl)nc21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29438116 1.00
SCHEMBL22309887 0.89
SCHEMBL29831329 0.89
SCHEMBL24589965 0.81
SCHEMBL23960162 0.78 PDE4A (0.33)
SCHEMBL16540545 0.74 SMN1; SMN2 (0.37)
SCHEMBL16540067 0.71 HRH3 (0.35)
SCHEMBL23960161 0.71 KDM4E (0.30)
SCHEMBL28856078 0.69 CDK2 (0.35)
SCHEMBL29831883 0.67 HTR2A (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240067633-A1 KETOHEXOKINASE INHIBITOR AND USE THEREOF XIZANG HAISCO PHARMACEUTICAL CO., LTD. (CN) 2024-02-29 US disclosed
US-20240067633-A1 KETOHEXOKINASE INHIBITOR AND USE THEREOF XIZANG HAISCO PHARMACEUTICAL CO., LTD. (CN) 2024-02-29 US disclosed
US-20230138901-A1 COMPOUND HAVING KHK INHIBITORY EFFECT HANGZHOU ZHONGMEIHUADONG PHARMACEUTICAL CO., LTD. (CN) 2023-05-04 US disclosed
US-20230138901-A1 COMPOUND HAVING KHK INHIBITORY EFFECT HANGZHOU ZHONGMEIHUADONG PHARMACEUTICAL CO., LTD. (CN) 2023-05-04 US disclosed
WO-2022262841-A1 SALT FORM AND CRYSTAL FORM OF SPIRO COMPOUND AND PREPARATION METHOD THEREFOR 杭州中美华东制药有限公司 2022-12-22 WO disclosed
CN-114989143-A Fused-ring ketohexokinase inhibitor and application thereof 山东轩竹医药科技有限公司 2022-09-02 CN disclosed
WO-2021129737-A1 COMPOUND HAVING KHK INHIBITORY EFFECT 南京明德新药研发有限公司 2021-07-01 WO disclosed
WO-2020156445-A1 HEXONE GLUCOKINASE INHIBITOR AND USE THEREOF 山东轩竹医药科技有限公司 2020-08-06 WO disclosed